UB Paderborn / Katalog / Suche / in CDI

microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers

Oncology reports, 2013-07, Vol.30 (1), p.320-326

2013

Volltextzugriff (PDF)

Genetic Testing in Hereditary Breast and Ovarian Cancer Using Massive Parallel Sequencing

BioMed research international, 2014-01, Vol.2014, p.542541-8

2014

Volltextzugriff (PDF)

Randomized Clinical Trial of Adjuvant Mitomycin Plus Tegafur in Patients With Resected Stage III Gastric Cancer

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3810-3815

1999

Volltextzugriff (PDF)

Adapted ice cream as a nutritional supplement in cancer patients: impact on quality of life and nutritional status

Clinical & translational oncology, 2012, Vol.14 (1), p.66-72

2012

Volltextzugriff (PDF)

Are breast cancer patients treated with radiotherapy younger now than ten years ago?

Reports of practical oncology and radiotherapy, 2015-01, Vol.20 (1), p.22-26

2015

Volltextzugriff (PDF)

Analysis of the Pathologic Response to Primary Chemotherapy in Patients with Locally Advanced Breast Cancer Grouped According to Estrogen Receptor, Progesterone Receptor, and HER2 Status

Clinical breast cancer, 2007-04, Vol.7 (7), p.559-564

2007

Volltextzugriff (PDF)

Extravasation of oxaliplatin: an infrequent and irritant toxicity

Clinical & translational oncology, 2009-02, Vol.11 (2), p.114-116

2009

Volltextzugriff (PDF)

Synchronous isolated adrenal metastasis from rectum adenocarcinoma

Clinical & translational oncology, 2009-04, Vol.11 (4), p.257-258

2009

Volltextzugriff (PDF)

Analysis and follow-up of the patients diagnosed with metastatic gastric adenocarcinoma in the Parc Taulí Hospital, Sabadell, between 2010 and 2013

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.169-169

2016

Volltextzugriff (PDF)

Efficacy and safety of chemotherapy DCX (DOCETAXEL–CISPLATIN–CAPECITABINE) as a perioperative treatment of gastric cancer: A single institution analysis

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16094-e16094

2018

Volltextzugriff (PDF)

Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer

European journal of cancer (1990), 2005-10, Vol.41 (15), p.2241-2249

2005

Volltextzugriff (PDF)

A real world analysis of recurrence risk factors for early colorectal cancer T1 treated with standard endoscopic resection

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.575-575

2018

Volltextzugriff (PDF)

Phase II study with docetaxel (D), cisplatin (C) and continuous capecitabine (X) schedule (DCX) in advanced gastric cancer (AGC): ML21085. Final results

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e15520-e15520

2016

Volltextzugriff (PDF)

Mediastinal extravasation of oxaliplatin

Clinical advances in hematology & oncology, 2012-08, Vol.10 (8), p.548-549

2012

Volltextzugriff (PDF)

P-0202 Expression Profile of Mirnas in Stage III Colorectal Tumours: Overexpressed Mirnas As Potential Circulating Biomarkers

Annals of oncology, 2012-06, Vol.23, p.iv88

2012

Volltextzugriff (PDF)

Phase II study of oxaliplatin and sorafenib in advanced gastric cancer after failure of cisplatin-fluoropyrimidine-based (PF) treatment

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4079-4079

2012

Volltextzugriff (PDF)

Haemolytic uraemic syndrome associated with gemcitabine

Clinical & translational oncology, 2010-05, Vol.12 (5), p.381-383

2010

Volltextzugriff (PDF)

Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer

Clinical & translational oncology, 2011, Vol.13 (1), p.61-66

2011

Volltextzugriff (PDF)

Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

BMC cancer, 2014-11, Vol.14 (1), p.865-865

2014

Volltextzugriff (PDF)

A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

Current medical research and opinion, 2008-10, Vol.24 (10), p.2931-2942

2008

Volltextzugriff (PDF)

Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2–T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME)

International journal of colorectal disease, 2018-02, Vol.33 (2), p.241-249

2018

Volltextzugriff (PDF)

Non-inferiority multicenter prospective randomized controlled study of rectal cancer T 2 -T 3s (superficial) N 0 , M 0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME)

International journal of colorectal disease, 2018-02

2018

Volltextzugriff (PDF)

Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRASmetastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

BMC cancer, 2014-11, Vol.14 (1), Article 865

2014

Volltextzugriff (PDF)

P3.03-056 Retrospective Study Comparing Two Frontline Chemotherapy Schemes in Unresectable Malignant Mesothelioma

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1380

2017

Volltextzugriff (PDF)

P3.03-055 Results of Second-Line Chemotherapy in Pleural Mesothelioma: A Single-Centre, Retrospective Study: Topic: Mesothelioma Clinical

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1379-S1380

2017

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers

Genetic Testing in Hereditary Breast and Ovarian Cancer Using Massive Parallel Sequencing

Randomized Clinical Trial of Adjuvant Mitomycin Plus Tegafur in Patients With Resected Stage III Gastric Cancer

Adapted ice cream as a nutritional supplement in cancer patients: impact on quality of life and nutritional status

Are breast cancer patients treated with radiotherapy younger now than ten years ago?

Analysis of the Pathologic Response to Primary Chemotherapy in Patients with Locally Advanced Breast Cancer Grouped According to Estrogen Receptor, Progesterone Receptor, and HER2 Status

Extravasation of oxaliplatin: an infrequent and irritant toxicity

Synchronous isolated adrenal metastasis from rectum adenocarcinoma

Analysis and follow-up of the patients diagnosed with metastatic gastric adenocarcinoma in the Parc Taulí Hospital, Sabadell, between 2010 and 2013

Efficacy and safety of chemotherapy DCX (DOCETAXEL–CISPLATIN–CAPECITABINE) as a perioperative treatment of gastric cancer: A single institution analysis

Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer

A real world analysis of recurrence risk factors for early colorectal cancer T1 treated with standard endoscopic resection

Phase II study with docetaxel (D), cisplatin (C) and continuous capecitabine (X) schedule (DCX) in advanced gastric cancer (AGC): ML21085. Final results

Mediastinal extravasation of oxaliplatin

P-0202 Expression Profile of Mirnas in Stage III Colorectal Tumours: Overexpressed Mirnas As Potential Circulating Biomarkers

Phase II study of oxaliplatin and sorafenib in advanced gastric cancer after failure of cisplatin-fluoropyrimidine-based (PF) treatment

Haemolytic uraemic syndrome associated with gemcitabine

Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer

Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

Non-inferiority multicenter prospective randomized controlled study of rectal cancer T2–T3s (superficial) N0, M0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME)

Non-inferiority multicenter prospective randomized controlled study of rectal cancer T 2 -T 3s (superficial) N 0 , M 0 undergoing neoadjuvant treatment and local excision (TEM) vs total mesorectal excision (TME)

Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRASmetastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

P3.03-056 Retrospective Study Comparing Two Frontline Chemotherapy Schemes in Unresectable Malignant Mesothelioma

P3.03-055 Results of Second-Line Chemotherapy in Pleural Mesothelioma: A Single-Centre, Retrospective Study: Topic: Mesothelioma Clinical

Suchergebnisse filtern